Page last updated: 2024-09-04

canertinib and Bone Neoplasms

canertinib has been researched along with Bone Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, LH; Giordano, TJ; Hughes, DP; McDonagh, KT; Thomas, DG	1

Other Studies

1 other study(ies) available for canertinib and Bone Neoplasms

Article	Year
Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition. Pediatric blood & cancer, 2006, May-01, Volume: 46, Issue:5 Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Membrane; Cell Nucleus; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Morpholines; Osteosarcoma; Phosphorylation; Receptor, ErbB-2; Receptor, ErbB-4; Tumor Cells, Cultured	2006

Article

Year

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition.

Pediatric blood & cancer, 2006, May-01, Volume: 46, Issue:5

Topics: Apoptosis; Blotting, Western; Bone Neoplasms; Cell Membrane; Cell Nucleus; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Morpholines; Osteosarcoma; Phosphorylation; Receptor, ErbB-2; Receptor, ErbB-4; Tumor Cells, Cultured

2006